Image placeholder title

Precision Cancer Medicines for Ovarian Cancer

Genomic testing identifies targets that can be treated with precision cancer medicines. ASCO 2021 update

Ovarian Cancer

Berzosertib - A Novel ATR Inhibitor in Development

ATR Inhibitor M6620 (VX-970) as monotherapy or in combination with chemotherapy in Colon and Ovarian Cancer